Biography/Memoir

[Synthetic patented psilocybin] are giving [some stock] investors a bad trip

It won’t be long before politicians trip together to resolve their differences… billionaire German investor Christian Angermayer, says. Right now, though, the charm offensive isn’t working so well. An exchange-traded fund tracking psychedelic stocks has lost two-thirds of its value since peaking last year. While some of these companies haven’t suffered as much… the comedown…

READ MORE
Biography/Memoir

Compass… updates on [synthetic polymorph] psilocybin…

Compass sinks after depression therapy results… the net loss for the year [2021] was $71.7 million…  …Compass doesn’t have any meaningful revenue… continues to explore… indications and therapeutic approaches… there were 12 people in the [synthetic psilocybin polymorph] study… who exhibited suicidal behavior or thoughts, or who showed intent to harm themselves. Original Article (Green Market…

READ MORE
Politics

…Compass Pathways’… patent…

Compass will now have three months to respond to each filing. Then, the Patent Trial and Appeal Board, a collection of administrative judges… will make a decision as to whether the petitioner demonstrates that at least one of the challenged claims is “more likely than not” unpatentable—and whether the case should proceed to a trial.…

READ MORE
Biography/Memoir

DEA to increase psilocybin… production for research purposes

The United States Drug Enforcement Administration (“DEA”) has proposed an increase in the manufacture… psilocin and psilocybin for clinical trial and research purposes… stated that its objective was to assist in the development of new federally approved therapies. …increased its production goals for psilocin and psilocybin, which are the main psychoactive components of magic mushrooms. Initially, the…

READ MORE
Biography/Memoir

[Compass Patent GB2572023B]… health

The right to use psychedelic[s] is currently navigating through the legislature, with places like Oregon, Washington DC, [et al.] decriminalizing psychedelic plant-based drugs… A revolution is sweeping mental health. Not since President Nixon declared war on drugs have researchers and traditional practitioners been able to share the results. The early data shows that plant-based therapy…

READ MORE
Science

…psychedelics boost brain growth factor levels?

Brain-derived neurotrophic factor (BDNF) regulates neuronal development and survival and triggers adaptive neuroplasticity… animal studies have reported that acute and chronic administration of various psychedelic compounds, including LSD, psilocybin, DMT, and other ayahuasca-derived alkaloids, can increase BDNF production and neurogenesis (the formation of new neurons). Importantly, threats to our well-being such as stress, ageing and…

READ MORE
Medicine/Healing

A future where your prescription reads “magic mushrooms”

…pop culture’s obsession with psychedelics may not be solely rooted in medicinal purposes… maybe, one day, there will be orange pill jars lining the shelves at CVS Pharmacy that read “psilocybin” in printed lettering. If society wishes to achieve “mass mental health,” [as] Rick Doblin… explains… his organization’s long-term goal is “mass mental health”… we…

READ MORE